Dr. Sharon Tuckett, MD

Hospice and Palliative Medicine Villa Rica, GA Female
NPI: 1285607648
Total Payments
$240,068
2024 Payments
$51,240
Companies
24
Transactions
286
Medicare Patients
2,819
Medicare Billing
$195,441

Payment Breakdown by Category

Consulting$237,807 (99.1%)
Food & Beverage$2,250 (0.9%)
Education$11.42 (0.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $237,807 137 99.1%
Food and Beverage $2,250 147 0.9%
Education $11.42 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $195,783 98 $0 (2024)
Shire North American Group Inc $42,065 42 $0 (2019)
Novo Nordisk Inc $410.62 26 $0 (2019)
AstraZeneca Pharmaceuticals LP $309.44 21 $0 (2020)
Janssen Pharmaceuticals, Inc $299.21 28 $0 (2020)
PFIZER INC. $199.27 11 $0 (2019)
Lilly USA, LLC $122.00 8 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $111.72 6 $0 (2019)
Amgen Inc. $108.45 7 $0 (2019)
Amarin Pharma Inc. $102.04 4 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $51,240 24 Takeda Pharmaceuticals U.S.A., Inc. ($51,240)
2023 $34,801 18 Takeda Pharmaceuticals U.S.A., Inc. ($34,787)
2022 $51,865 25 Takeda Pharmaceuticals U.S.A., Inc. ($51,865)
2021 $33,412 18 Takeda Pharmaceuticals U.S.A., Inc. ($33,412)
2020 $24,526 17 Takeda Pharmaceuticals U.S.A., Inc. ($24,479)
2019 $19,282 52 Shire North American Group Inc ($18,719)
2018 $11,940 73 Shire North American Group Inc ($10,948)
2017 $13,003 59 Shire North American Group Inc ($12,398)

All Payment Transactions

286 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,193.33 General
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
02/14/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
02/14/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
01/17/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
01/17/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
12/15/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,093.33 General
123…12»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 710 916 $161,435 $54,231
2022 15 740 1,033 $146,237 $51,223
2021 14 652 876 $110,811 $46,444
2020 16 717 1,092 $103,687 $43,542
Total Patients
2,819
Total Services
3,917
Medicare Billing
$195,441
Procedure Codes
55

All Medicare Procedures & Services

55 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 164 252 $77,112 $20,219 26.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 146 146 $35,624 $19,046 53.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 121 165 $35,805 $9,994 27.9%
90732 Pneumococcal vaccine, 23-valent Office 2023 20 20 $6,600 $2,616 39.6%
83036 Hemoglobin a1c level Office 2023 44 71 $1,704 $675.92 39.7%
G0009 Administration of pneumococcal vaccine Office 2023 23 23 $644.00 $631.12 98.0%
96372 Injection of drug or substance under skin or into muscle Office 2023 26 51 $2,448 $490.88 20.1%
81003 Automated urinalysis test Office 2023 123 139 $695.00 $305.80 44.0%
82044 Urine microalbumin (protein) analysis Office 2023 29 31 $434.00 $189.41 43.6%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2023 14 18 $369.00 $63.36 17.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 191 300 $83,700 $24,675 29.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 124 124 $30,256 $16,453 54.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 52 61 $11,956 $3,268 27.3%
90732 Pneumococcal vaccine, 23-valent Office 2022 12 12 $3,960 $1,586 40.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 14 14 $5,054 $1,281 25.3%
96372 Injection of drug or substance under skin or into muscle Office 2022 24 79 $3,792 $812.73 21.4%
90662 Influenza vaccine split virus, preservative free Office 2022 11 11 $1,694 $753.94 44.5%
83036 Hemoglobin a1c level Office 2022 45 70 $1,680 $671.84 40.0%
G0009 Administration of pneumococcal vaccine Office 2022 19 19 $532.00 $526.12 98.9%
81003 Automated urinalysis test Office 2022 138 172 $860.00 $381.35 44.3%
G0008 Administration of influenza virus vaccine Office 2022 11 11 $319.00 $312.62 98.0%
82044 Urine microalbumin (protein) analysis Office 2022 36 36 $504.00 $222.84 44.2%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2022 36 58 $406.00 $188.06 46.3%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2022 16 18 $324.00 $73.02 22.5%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2022 11 48 $1,200 $17.41 1.5%
123»

About Dr. Sharon Tuckett, MD

Dr. Sharon Tuckett, MD is a Hospice and Palliative Medicine healthcare provider based in Villa Rica, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285607648.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharon Tuckett, MD has received a total of $240,068 in payments from pharmaceutical and medical device companies, with $51,240 received in 2024. These payments were reported across 286 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($237,807).

As a Medicare-enrolled provider, Tuckett has provided services to 2,819 Medicare beneficiaries, totaling 3,917 services with total Medicare billing of $195,441. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.

Practice Information

  • Specialty Hospice and Palliative Medicine
  • Other Specialties Internal Medicine
  • Location Villa Rica, GA
  • Active Since 02/08/2006
  • Last Updated 02/13/2019
  • Taxonomy Code 207RH0002X
  • Entity Type Individual
  • NPI Number 1285607648

Products in Payments

  • FARXIGA (Drug) $259.10
  • XARELTO (Drug) $195.90
  • Victoza (Drug) $144.60
  • Saxenda (Drug) $134.59
  • INVOKANA (Drug) $103.31
  • Vascepa (Drug) $102.04
  • PREVNAR - 13 (Biological) $100.97
  • ENTRESTO (Drug) $83.43
  • CHANTIX (Drug) $82.17
  • JARDIANCE (Drug) $71.54
  • TRULICITY (Drug) $58.63
  • TRADJENTA (Drug) $57.20
  • Ozempic (Drug) $57.03
  • SOLIQUA (Drug) $50.12
  • SUBSYS (Drug) $40.35
  • MYRBETRIQ (Drug) $37.43
  • Aimovig (Biological) $36.03
  • Tymlos (Biological) $34.76
  • EMGALITY (Drug) $31.73
  • Repatha (Biological) $29.16

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.